Watch the video here: bit.ly/qualitytransformation_ondemand
Transforming quality management to make it easier to comply with regulations and enable faster and more informed decisions is disruptive – impacting people, processes, and systems. With a business case demonstrating anticipated benefits and savings, teams can justify the costs for change, gain stakeholder support, and ensure alignment.
Many organizations have a fragmented system landscape and outdated or manual quality processes. Leading companies are migrating to modern, cloud systems to enable continuous improvement and accelerate transformation initiatives. They are also re-evaluating processes – adopting current best practices and optimizing investments in new technology.
By watching this on demand webinar with quality experts from PriceWaterhouseCoopers (PwC) and Veeva Systems. You will learn how to build a business case to support quality management transformations including:
• Getting a framework for developing business cases
• How to move from a cost to value structure leveraging Quality 4.0
• Recommendations on calculating TCO with key considerations
• Guidance on navigating complex organizations to gain support
Who Will Benefit:
• VP/Director of Quality and Compliance (QA or QC), Quality Systems
• VP/Director of Information Technology, Quality Management Systems, Quality Systems
• VP/Director of Manufacturing Operations/ Quality Operations/ Supply Chain
• Document/Records Managers/ Directors
• Director, Regulatory Operations/ Regulatory Affairs (CMC – Chemistry, Manufacturing, and Control)
• IT System Administrators
• Quality Training Coordinator
Meet Your Presenters:
Jan Paul (JP) Zonnenberg
Partner, Pharmaceutical and Life Sciences Companies, PwC
As a Partner and co-Lead for PwC’s Quality Management Systems Practice, JP’s concentration is in global operations and specifically in quality systems and QMS information technology within the Life Sciences Business Group. With over 28 years’ experience in pharmaceuticals, biotechnology, and medical devices & diagnostics, JP helps leading companies proactively think about developing next generation quality systems to ensure both effective and efficient organizations.
Mike Jovanis
VP Vault Quality, Veeva Systems
As Vice President of the Vault Quality product suite, Mike is responsible for product strategy, customer engagement, and business development. Previously, he served as vice president of product management and strategy for Sparta Systems, where he was instrumental in the company's rapid growth, driving product development, vertical market strategy, and strategic partner alliances. Educated at Rutgers, he holds a bachelor’s degree in marketing and an MBA in strategy and global business.
13. PwC
Quality is evolving from a compliance-centric to a product &
patient-centric approach
13
Patient
Centric
Product
Centric
Compliance
Centric
Quality is focused on ensuring effectiveness of treatment,
patient quality-of-life and driving revenue growth
Quality is focused on designing and manufacturing highly
reliable products with highly capable processes and driving
tangible bottom line ROI
Quality is primarily focused on meeting regulatory
requirements and is considered a cost-of-doing business
14. PwC
Organizational
DNA / Culture
Processes &
Procedures
Digital
Quality
Scientific &
Operational
Excellence
This transformation requires a structured approach
14
Quality 4.0 framework
Quality
Outcomes
The 4 Quality
Elements Centered
around the patient
Patient
Centric
Product
Centric
Compliance
Centric
16. PwC
Measuring Quality Outcomes & Business Value
16
Quality
Outcomes
Business Value - Return on Investment (ROI)
Metrics Revenue Costs Inventory Reg. Risk
Competitive
Compliance
Innovation
Speed to
Market
Robust Products
& Data
Reliable
Supply
17. PwC
Measuring Quality Outcomes & Business Value
17
Quality
Outcomes
Business Value - Return on Investment (ROI)
Metrics Revenue Costs Inventory Reg. Risk
Competitive
Compliance
• Culture & Employee Engagement
• Audit & Inspection Observations
• Recall & Deviation Rates
• Supplier Risk Profile
• Total Cost of Quality
Compliance Risk Dashboard
Innovation
• Use of Modern Mfg. Processes & Analytical Automation
• Use of Emerging Technologies (e.g.: AI, Analytics)
• Adoption of Enterprise Quality Systems
• Use of Adaptive Clinical Trial Design
• Use of QbD, QRM, CPV, etc.
Speed to
Market
• LPO – Database Lock & CSR (by study)
• LPO – 1st Major MAA Approval
• Protocol Amendment Rate
• Serious Breach & Critical Data Error Rate
• % Post Approval Changes approved on time
Robust Products
& Data
• Product & Process Knowledge (data)
• Brand Image (Patient perspective)
• Release Cycle Time (& variability)
• Yield, OOS, OOT, OEE, Cpk
• Complaint Rate
Product Quality Dashboard
Reliable
Supply
• E2E Cycle Time (DS, DP, FG, Customer Shipment)
• Manufacturing Schedule Adherence
• Service Levels (on time, in full)
• Shipping-Related Complaints
• % Dual Sourced Supply
Competitive Compliance
• Culture & Employee Engagement
• Audit & Inspection Observations
• Recall & Deviation Rates
• Supplier Risk Profile
• Total Cost of Quality
Compliance Risk Dashboard
Reduces Cost & Regulatory Risk
18. PwC
Measuring Quality Outcomes & Business Value
18
Quality
Outcomes
Business Value - Return on Investment (ROI)
Metrics Revenue Costs Inventory Reg. Risk
Competitive
Compliance
• Culture & Employee Engagement
• Audit & Inspection Observations
• Recall & Deviation Rates
• Supplier Risk Profile
• Total Cost of Quality
Compliance Risk Dashboard
Innovation
• Use of Modern Mfg. Processes & Analytical Automation
• Use of Emerging Technologies (e.g.: AI, Analytics)
• Adoption of Enterprise Quality Systems
• Use of Adaptive Clinical Trial Design
• Use of QbD, QRM, CPV, etc.
Speed to
Market
• LPO – Database Lock & CSR (by study)
• LPO – 1st Major MAA Approval
• Protocol Amendment Rate
• Serious Breach & Critical Data Error Rate
• % Post Approval Changes approved on time
Robust Products
& Data
• Product & Process Knowledge (data)
• Brand Image (Patient perspective)
• Release Cycle Time (& variability)
• Yield, OOS, OOT, OEE, Cpk
• Complaint Rate
Product Quality Dashboard
Reliable
Supply
• E2E Cycle Time (DS, DP, FG, Customer Shipment)
• Manufacturing Schedule Adherence
• Service Levels (on time, in full)
• Shipping-Related Complaints
• % Dual Sourced Supply
Innovation
• Use of Modern Mfg. Processes & Analytical
Automation
• Use of Emerging Technologies (e.g.: AI,
Analytics)
• Adoption of Enterprise Quality Systems
• Use of Adaptive Clinical Trial Design
• Use of QbD, QRM, CPV, etc.
Reduces Cost & Regulatory Risk
19. PwC
Measuring Quality Outcomes & Business Value
19
Quality
Outcomes
Business Value - Return on Investment (ROI)
Metrics Revenue Costs Inventory Reg. Risk
Competitive
Compliance
• Culture & Employee Engagement
• Audit & Inspection Observations
• Recall & Deviation Rates
• Supplier Risk Profile
• Total Cost of Quality
Compliance Risk Dashboard
Innovation
• Use of Modern Mfg. Processes & Analytical Automation
• Use of Emerging Technologies (e.g.: AI, Analytics)
• Adoption of Enterprise Quality Systems
• Use of Adaptive Clinical Trial Design
• Use of QbD, QRM, CPV, etc.
Speed to
Market
• LPO – Database Lock & CSR (by study)
• LPO – 1st Major MAA Approval
• Protocol Amendment Rate
• Serious Breach & Critical Data Error Rate
• % Post Approval Changes approved on time
Robust Products
& Data
• Product & Process Knowledge (data)
• Brand Image (Patient perspective)
• Release Cycle Time (& variability)
• Yield, OOS, OOT, OEE, Cpk
• Complaint Rate
Product Quality Dashboard
Reliable
Supply
• E2E Cycle Time (DS, DP, FG, Customer Shipment)
• Manufacturing Schedule Adherence
• Service Levels (on time, in full)
• Shipping-Related Complaints
• % Dual Sourced Supply
Speed to Market
• LPO- Database Lock & CSR (by study)
• LPO-1st Major MAA Approval
• Protocol Amendment Rate
• Serious Breach & Critical Data Error Rate
• % Post Approval Changes approved on
time
Increases Revenue
20. PwC
Measuring Quality Outcomes & Business Value
20
Quality
Outcomes
Business Value - Return on Investment (ROI)
Metrics Revenue Costs Inventory Reg. Risk
Competitive
Compliance
• Culture & Employee Engagement
• Audit & Inspection Observations
• Recall & Deviation Rates
• Supplier Risk Profile
• Total Cost of Quality
Compliance Risk Dashboard
Innovation
• Use of Modern Mfg. Processes & Analytical Automation
• Use of Emerging Technologies (e.g.: AI, Analytics)
• Adoption of Enterprise Quality Systems
• Use of Adaptive Clinical Trial Design
• Use of QbD, QRM, CPV, etc.
Speed to
Market
• LPO – Database Lock & CSR (by study)
• LPO – 1st Major MAA Approval
• Protocol Amendment Rate
• Serious Breach & Critical Data Error Rate
• % Post Approval Changes approved on time
Robust Products
& Data
• Product & Process Knowledge (data)
• Brand Image (Patient perspective)
• Release Cycle Time (& variability)
• Yield, OOS, OOT, OEE, Cpk
• Complaint Rate
Product Quality Dashboard
Reliable
Supply
• E2E Cycle Time (DS, DP, FG, Customer Shipment)
• Manufacturing Schedule Adherence
• Service Levels (on time, in full)
• Shipping-Related Complaints
• % Dual Sourced Supply
Robust Products & Data
• Product & Process Knowledge (data)
• Brand Image (Patient perspective)
• Release Cycle Time (& variability)
• Yield, OOS, OOT, OEE, Cpk
• Complaint Rate
Product Quality Dashboard
Increases Revenue, Reduces Cost,
Inventory & Regulatory Risk
21. PwC
Measuring Quality Outcomes & Business Value
21
Quality
Outcomes
Business Value - Return on Investment (ROI)
Metrics Revenue Costs Inventory Reg. Risk
Competitive
Compliance
• Culture & Employee Engagement
• Audit & Inspection Observations
• Recall & Deviation Rates
• Supplier Risk Profile
• Total Cost of Quality
Compliance Risk Dashboard
Innovation
• Use of Modern Mfg. Processes & Analytical Automation
• Use of Emerging Technologies (e.g.: AI, Analytics)
• Adoption of Enterprise Quality Systems
• Use of Adaptive Clinical Trial Design
• Use of QbD, QRM, CPV, etc.
Speed to
Market
• LPO – Database Lock & CSR (by study)
• LPO – 1st Major MAA Approval
• Protocol Amendment Rate
• Serious Breach & Critical Data Error Rate
• % Post Approval Changes approved on time
Robust Products
& Data
• Product & Process Knowledge (data)
• Brand Image (Patient perspective)
• Release Cycle Time (& variability)
• Yield, OOS, OOT, OEE, Cpk
• Complaint Rate
Product Quality Dashboard
Reliable
Supply
• E2E Cycle Time (DS, DP, FG, Customer Shipment)
• Manufacturing Schedule Adherence
• Service Levels (on time, in full)
• Shipping-Related Complaints
• % Dual Sourced Supply
Reliable Supply
• E2E Cycle Time (DS, DP, FG, Customer
shipment)
• Manufacturing Schedule Adherence
• Service Levels (on time, in full)
• Shipping- Related Complaints
• % Dual Sourced Supply
Increases Revenue
& Reduces Inventory
22. PwC
Measuring Quality Outcomes & Business Value
22
Quality
Outcomes
Business Value - Return on Investment (ROI)
Metrics Revenue Costs Inventory Reg. Risk
Competitive
Compliance
• Culture & Employee Engagement
• Audit & Inspection Observations
• Recall & Deviation Rates
• Supplier Risk Profile
• Total Cost of Quality
Compliance Risk Dashboard
Innovation
• Use of Modern Mfg. Processes & Analytical Automation
• Use of Emerging Technologies (e.g.: AI, Analytics)
• Adoption of Enterprise Quality Systems
• Use of Adaptive Clinical Trial Design
• Use of QbD, QRM, CPV, etc.
Speed to
Market
• LPO – Database Lock & CSR (by study)
• LPO – 1st Major MAA Approval
• Protocol Amendment Rate
• Serious Breach & Critical Data Error Rate
• % Post Approval Changes approved on time
Robust Products
& Data
• Product & Process Knowledge (data)
• Brand Image (Patient perspective)
• Release Cycle Time (& variability)
• Yield, OOS, OOT, OEE, Cpk
• Complaint Rate
Product Quality Dashboard
Reliable
Supply
• E2E Cycle Time (DS, DP, FG, Customer Shipment)
• Manufacturing Schedule Adherence
• Service Levels (on time, in full)
• Shipping-Related Complaints
• % Dual Sourced Supply
23. PwC
Quality
Outcomes
Business Value - Return on Investment (ROI)
Revenue Costs Inventory Reg. Risk
Competitive
Compliance
Innovation
Speed to
Market
Robust Products
& Data
Reliable
Supply
Calculating the Business Value (ROI)
23
Potential ROI for a $10 B Company
1% increase in revenue $100 M
25% reduction in cost of quality* $75 - 125 M
Total annual benefit $175 - 225 M
Market Capitalization @ 10x PE ratio $1.75 – 2.25 B
10% improvement in inventory turns** $90 M
Cost avoidance of Warning Letter***
Cost avoidance of Consent Decree
$5 - 50 M
$ .2 – 2 B
* Cost of quality is typically 3-5% of revenue, a 25% reduction equals 1-2% of revenue
** Increasing turns from 2 to 2.2 on COGS of 20% of revenue for a 1 time free cash flow
*** PWC Estimates (including cost of remediation, cost of QMS transformation, lost revenue)
24. PwC
Quality
Outcomes
Business Value - Return on Investment (ROI)
Revenue Costs Inventory Reg. Risk
Competitive
Compliance
Innovation
Speed to
Market
Robust Products
& Data
Reliable
Supply
Calculating the Business Value (ROI)
24
Potential ROI for a $10 B Company
1% increase in revenue $100 M
25% reduction in cost of quality* $75 - 125 M
Total annual benefit $175 - 225 M
Market Capitalization @ 10x PE ratio $1.75 – 2.25 B
10% improvement in inventory turns** $90 M
Cost avoidance of Warning Letter***
Cost avoidance of Consent Decree
$5 - 50 M
$ .2 – 2 B
* Cost of quality is typically 3-5% of revenue, a 25% reduction equals 1-2% of revenue
** Increasing turns from 2 to 2.2 on COGS of 20% of revenue for a 1 time free cash flow
*** PWC Estimates (including cost of remediation, cost of QMS transformation, lost revenue)
25. PwC
The value of an integrated QMS
25
Quality
Outcomes
Business Value - Return on Investment (ROI)
Revenue Costs Inventory Reg. Risk
Competitive
Compliance
Innovation
Speed to
Market
Robust Products
& Data
Reliable
Supply
Reduced product withdrawals
Introduction of new technologies (e.g.: gene therapy)
Faster product approvals & launches (LPO to Filing)
Brand reputation in developing markets
More robust clinical studies and data
Improved tender win rates
Reduced product shortages
Fulfill unexpected increases in demand
Revenue
26. PwC
The value of an integrated QMS
26
Quality
Outcomes
Business Value - Return on Investment (ROI)
Revenue Costs Inventory Reg. Risk
Competitive
Compliance
Innovation
Speed to
Market
Robust Products
& Data
Reliable
Supply
Total Cost of eQMS / eDMS Ownership
Reduction in # of deviations, CAPAs & recalls
Reduction in Operations and QA headcount
Reduction in hours on training
Reduction in serious breaches
Reduction in protocol amendments
Improved yields, Right First Time, OEE, Cpk
Reduction in # of complaints
Reduced capital expenditures
Cost
27. PwC
The value of an integrated QMS
27
Quality
Outcomes
Business Value - Return on Investment (ROI)
Revenue Costs Inventory Reg. Risk
Competitive
Compliance
Innovation
Speed to
Market
Robust Products
& Data
Reliable
Supply
In line, reduced testing reqs., modern / rapid testing technologies
Shorter E2E cycle time from RM, API, DP, Packaged product in
country available for sale
Reduced testing, disposition LT, processing at risk, QP in country
Inventory
28. PwC
The value of an integrated QMS
28
Quality
Outcomes
Business Value - Return on Investment (ROI)
Revenue Costs Inventory Reg. Risk
Competitive
Compliance
Innovation
Speed to
Market
Robust Products
& Data
Reliable
Supply
Reduction in Risk profile
Reduced # of inspection days & findings
Self identified improvement opportunities
Reg. Risk
29. PwC
The value of an integrated QMS
29
Quality
Outcomes
Business Value - Return on Investment (ROI)
Revenue Costs Inventory Reg. Risk
Competitive
Compliance
• Reduced product withdrawals • Total Cost of eQMS / eDMS
Ownership
• Reduction in Operations and
QA costs
• Reduction in # of deviations,
CAPAs & recalls
• Reduction in Risk profile
• Reduced number of inspection
days & findings
Innovation
• Introduction of new technologies
(e.g.: gene therapy)
• Reduction in hours on training • In line testing, reduced testing
requirements, modern / rapid
testing technologies, etc.
• Self identified improvement
opportunities
Speed to
Market
• Faster product approvals &
launches (LPO to Filing)
• Reduction in serious breaches
• Reduction in protocol
amendments
Robust Products
& Data
• Brand reputation in developing
markets
• More robust clinical studies and
data
• Improved tender win rates
• Improved yields
• Improved Right First Time
• Improved OEE, Cpk
• Reduction in # of complaints
• Reduced capital expenditures
Reliable
Supply
• Reduced product shortages
• Fulfill unexpected increases in
demand
• Shorter E2E cycle time from RM,
API, DP, Packaged product in
country available for sale
• Reduced testing, disposition LT,
processing at risk, QP in country
30. PwC
The value of an integrated QMS – Total Cost of Ownership
30
Quality
Outcomes
Business Value - Return on Investment (ROI)
Revenue Costs Inventory Reg. Risk
Competitive
Compliance
• Total Cost of eQMS / eDMS
Ownership
Innovation
Speed to
Market
Robust Products
& Data
Reliable
Supply
31. PwC
The Value of an Integrated QMS – Cost Reduction
31
Quality
Outcomes
Business Value - Return on Investment (ROI)
Revenue Costs Inventory Reg. Risk
Competitive
Compliance
• Total Cost of eQMS / eDMS
Ownership
• Reduction in Operations and
QA costs
Innovation
Speed to
Market
Robust Products
& Data
Reliable
Supply
32. PwC
CxO Talking Points
Talking the language of the CxO
32
Improving the brand imageCEO
COO
CFO
CCO
CQO
CSO
Robustness of processes & products
Improved yields & cycle times
Reduction in overall cost of (poor) quality
Total cost of ownership for eQMS / eDMS
Speed to market & reliability of supply
Competitive Compliance
Higher compliance at reduced cost
Reduced # of Protocol Deviations & Amendments
Robustness & speed of clinical trials & approvals
(Commercial)
(Quality)
(Science)
(Finance)
(Operation)
(Executive)
Building a Business Case for Quality Management Transformation
Transforming quality management to make it easier to comply with regulations and enable faster and more informed decisions is disruptive – impacting people, processes, and systems. With a business case demonstrating anticipated benefits and savings, teams can justify the costs for change, gain stakeholder support, and ensure alignment.
Many organizations have a fragmented system landscape and outdated or manual quality processes. Leading companies are migrating to modern, cloud systems to enable continuous improvement and accelerate transformation initiatives. They are also re-evaluating processes – adopting current best practices and optimizing investments in new technology.
Join us on Wednesday, July 17 for a live webinar with quality experts from PriceWaterhouseCoopers (PwC) and Veeva Systems. You will learn how to build a business case to support quality management transformations including:
Getting a framework for developing business cases
How to move from a cost to value structure leveraging Quality 4.0
Recommendations on calculating TCO with key considerations
Guidance on navigating complex organizations to gain support
The first slide should setup the industry drivers of why the first wave of industry adoption occurred
It should have the context set that this was over a continuum of time from late 90’s until recent times. We could use a visual for this.
Perhaps more of the real estate on the slide is a set of visuals that sequence in from left to right to set up these points.
Emergence of 21 CFR Part 11
Necessity of replacing home grown applications & manual processes
Remediation of plant and line of business specific compliance challenges
Fragmented IT strategy --- quality systems not yet recognized as strategic
Left is what is happening and the right is the impact / challenge
This is the transition to the investment piece
There should be two points, point one is sum of many smaller incremental projects over a period of 20 years setup in the last slide,
the second point is the reality of cyclical investment that is based on compliance issues and individualized investments.
This could potentially be one visual that covers both.
New slide ---- What is different today
Large transformative investments, singular implementations, not incremental overtime
Many companies have never built business cases for singular, enterprise projects of this scope in the quality area
True shifts to the cloud have a significantly different TCO footprint. Large amount of cost is
Great opportunity for creating value --- not just achieving compliance
This requires different thinking when it comes to building a business case
--- cloud alternatives now exist and are being actively implemented, offer a transformative set of benefits vs. the legacy in place --- we may want to share market observations x/y top N companies engaging in transformative projects
2nd slide --- talk about how this is categorically different then the past
---large transformative implementations, not reactive to regulatory challenges but more positioned to deliver value to the business --- value driven, not drive by necessity of compliance or quality
Enumerate cloud benefits ---- 3 releases per year, industry cloud notion of best practices across multiple dimensions, unification in and out of quality, standardization of process, integration of third parties
Cloud
All QMS elements brought together into a single system with standardized processes and data model
Unification of disparate quality applications onto a single platform
Interconnections between applications are standardized and maintained
Exciting time to create value and transform quality management
Larger transformative topics